Literature DB >> 27595830

Immune complexes that contain HIV antigens activate peripheral blood T cells.

L B Korolevskaya1,2, K V Shmagel3,4, E V Saidakova3,4, N G Shmagel4,5, V A Chereshnev4,6.   

Abstract

Uninfected donor T cells were treated in vitro by model immune complexes that contained either HIV or hepatitis C virus (HCV) antigens. Unlike HCV antigen-containing complexes, the immune complexes that contained HIV antigens have been shown to activate peripheral blood T cells of uninfected donors under in vitro conditions. Both the antiviral antibodies and HIV antigen were involved in the activation process. The unique properties of the immune complexes formed by HIV antigens and antiviral antibodies are believed to result from the virus-specific antibody properties and molecular conformation of the antigen-antibody complex.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27595830     DOI: 10.1134/S0012496616040062

Source DB:  PubMed          Journal:  Dokl Biol Sci        ISSN: 0012-4966


  13 in total

1.  Immune activation and AIDS pathogenesis.

Authors:  Donald L Sodora; Guido Silvestri
Journal:  AIDS       Date:  2008-02-19       Impact factor: 4.177

2.  Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.

Authors:  Tim Rhodes; Lucy Platt; Ali Judd; Larissa Albertovna Mikhailova; Anya Sarang; Nigel Wallis; Tatiana Alpatova; Matthew Hickman; John V Parry
Journal:  Int J STD AIDS       Date:  2005-11       Impact factor: 1.359

3.  Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation.

Authors:  A Caruso; S Licenziati; M Corulli; A D Canaris; M A De Francesco; S Fiorentini; L Peroni; F Fallacara; F Dima; A Balsari; A Turano
Journal:  Cytometry       Date:  1997-01-01

Review 4.  Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies.

Authors:  Peter D Kwong; John R Mascola
Journal:  Immunity       Date:  2012-09-21       Impact factor: 31.745

Review 5.  Mechanism of HIV pathogenesis: role of superantigens in disease.

Authors:  B A Torres; T Tanabe; P S Subramaniam; J K Yamamoto; H M Johnson
Journal:  Alcohol Clin Exp Res       Date:  1998-08       Impact factor: 3.455

6.  Infectious immune complexes in HIV-1-infected patients.

Authors:  S A Fiscus; J D Folds; C M van der Horst
Journal:  Viral Immunol       Date:  1993       Impact factor: 2.257

7.  High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treatment.

Authors:  Veronica D Gonzalez; Karolin Falconer; Kim G Blom; Olle Reichard; Birgitte Mørn; Alex Lund Laursen; Nina Weis; Annette Alaeus; Johan K Sandberg
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

Review 8.  Chronic innate immune activation as a cause of HIV-1 immunopathogenesis.

Authors:  Adriano Boasso; Gene M Shearer
Journal:  Clin Immunol       Date:  2007-10-03       Impact factor: 3.969

9.  Circulating immune complexes in chronic hepatitis C.

Authors:  J F Tsai; J E Jeng; W Y Chang; M S Ho; Z Y Lin; J H Tsai
Journal:  J Med Virol       Date:  1995-05       Impact factor: 2.327

Review 10.  HIV disease: fallout from a mucosal catastrophe?

Authors:  Jason M Brenchley; David A Price; Daniel C Douek
Journal:  Nat Immunol       Date:  2006-03       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.